髓外病变对初诊多发性骨髓瘤患者预后的影响

OBJECTIVE: To summarize the characteristics of patients with newly diagnosed multiple myeloma（NDMM）admitted at Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine. We compared the clinical characteristics and prognoses among patients with non-extramedullary disease（EMD）, bone-related extramedullary（EM-B）disease, and extraosseous extramedullary（EM-E）disease and further explored the effects of autologous hematopoietic stem cell transplantation（ASCT）for EMD. METHODS: From January 2015 to January 2022, data of 114 patients（22％）with EMD out of 515 patients with NDMM were retrospectively analyzed; 91（18％）and 23（4％）patients comprised the EM-B and EM-E groups, respectively. The clinical characteristics of patients in all groups were compared with the Chi-square test. Progression-free survival（PFS）and overall survival（OS）of patients were analyzed by the Kaplan-Meier method. Independent prognostic factors were determined using multivariate Cox proportional hazard model. RESULTS: There were no significant differences in age, gender, ISS stage, light chain, creatinine clearance, cytogenetic risk, 17p deletion, ASCT, and induction regimens among the three groups. Overall, 13％ of EM-E patients had IgD-type M protein, which was significantly higher than that in EM-B patients（P＝0.021）. The median PFS of patients in the non-EMD, EM-B, and EM-E groups was 27.4, 23.1, and 14.0 months; the median OS was not reached, 76.8 months, and 25.6 months, respectively. The PFS（vs non-EMD, P＝0.004; vs EM-B, P＝0.036）and OS（vs non-EMD, P<0.001; vs EM-B, P＝0.002）were significantly worse in patients with EM-E, while those were not significantly different between patients with EM-B and those with non-EMD. In the multivariate analysis, EM-E was an independent prognostic factor for OS in patients with NDMM（HR＝8.779, P<0.001）and negatively impacted PFS（HR＝1.874, P＝0.050）. In those who did not undergo ASCT, patients with EM-B had significantly worse OS than those with non-EMD（median 76.8 months vs. not reached, P＝0.029）. However, no significant difference was observed in the PFS and OS of patients with EM-B and those with non-EMD who underwent ASCT. CONCLUSION: Compared to patients with either non-EMD or EM-B, those with EM-E had the worst prognosis. EM-E was an independent risk factor for OS in patients with NDMM. ASCT can overcome the poor prognosis of EM-B.